CWIG
ALNY icon

Chung Wu Investment Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Chung Wu Investment Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.91K Hold
13
– – ﹤0.01% 261
2026
Q1 		$4.3K Hold
13
– – ﹤0.01% 233
2025
Q4 		$5.17K Hold
13
– – ﹤0.01% 237
2025
Q3 		$5.93K Hold
13
– – ﹤0.01% 230
2025
Q2 		$4.24K Buy
+13
New +$3.6K ﹤0.01% 236

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Chung Wu Investment Group's ALNY Position: Q2 2026 in Review

Chung Wu Investment Group held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 13 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #261.

Chung Wu Investment Group first reported a position in ALNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.93K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Chung Wu Investment Group held 13 shares of Alnylam Pharmaceuticals worth $3.91K as of Q2 2026.
  • Chung Wu Investment Group left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Chung Wu Investment Group's portfolio in Q2 2026, its #261 holding.
  • Chung Wu Investment Group first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Chung Wu Investment Group's Alnylam Pharmaceuticals position peaked at $5.93K in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Chung Wu Investment Group's 13F filing for Q2 2026, filed 31 Jul 2026.